| Bioactivity | Tulrampator (CX-1632) is an orally bioavailable positive AMPAR (allosteric modulator of AMPA receptor). Antidepressant[1]. | ||||||||||||
| Target | AMPAR | ||||||||||||
| Name | Tulrampator | ||||||||||||
| CAS | 1038984-31-4 | ||||||||||||
| Formula | C20H17FN4O3 | ||||||||||||
| Molar Mass | 380.37 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Wilkinson ST, et al. A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate/GABA neurotransmitter systems. Drug Discov Today. 2018 Nov 14. pii: S1359-6446( |
Tulrampator
CAS: 1038984-31-4 F: C20H17FN4O3 W: 380.37
Tulrampator (CX-1632) is an orally bioavailable positive AMPAR (allosteric modulator of AMPA receptor). Antidepressant.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.